LianBio Gets Chinese Biotech US IPOs Rolling Again But Followers Scant

Health Players Turn Inward-Looking

 
• By Brian Yang

Billed as BridgeBio in China, US-based and China-oriented biotech LianBio breaks a long hiatus in US listing for Chinese biotechs.

Nasdaq ipo
LIANBIO IPO STARTS CHINESE US IPOS ROLLING AGAIN BUT FOLLOWERS MAY BE SCANT • Source: Alamy

More from Financing

More from Business